Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis

This publication has 33 references indexed in Scilit:

• Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis
  Neurobiology of Disease, 2004
• Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors
  Proceedings of the National Academy of Sciences, 2002
• In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice
  Nature Medicine, 2001
• Long-Term and Significant Correction of Brain Lesions in Adult Mucopolysaccharidosis Type VII Mice Using Recombinant AAV Vectors
  Molecular Therapy, 2000
• The neuronal ceroid‐lipofuscinoses (Batten disease): A new class of lysosomal storage diseases
  Journal of Inherited Metabolic Disease, 1999
• Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease
  Proceedings of the National Academy of Sciences, 1999
• Neonatal Intramuscular Injection with Recombinant Adeno-Associated Virus Results in Prolonged beta-Glucuronidase Expression in Situ and Correction of Liver Pathology in Mucopolysaccharidosis Type VII Mice
  Human Gene Therapy, 1999
• Cell Lines for the Production of Recombinant Adeno-Associated Virus
  Human Gene Therapy, 1995
• Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation
  Blood, 1991
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976